Croda International Plc, a global leader in specialty ingredients and a Catalonia.health member company, has announced a strategic supply partnership with Amino GmbH, a leading manufacturer of pharmaceutical-grade amino acids, aimed at strengthening the global availability of high purity amino acids for pharmaceutical formulation and biomanufacturing.

Expansion of Bioprocessing Capabilities

Combining Croda's deep expertise in smart science and global market reach, with Amino's advanced capabilities in the precision manufacturing of amino acids will enable Croda to deliver even more innovative, high-quality solutions that help customers accelerate their product development and achieve greater efficiency.

Launch of BioXPro™

This strategic partnership is accompanied by the launch of BioXPro™, which reinforces Croda's commitment to supplying the highest purity ingredients for pharmaceutical formulation and biomanufacturing. This launch follows on from the recent launches of Virodex™ for viral inactivation and cell lysis, and Super Refined™ Poloxamer 188 as a shear protectant in cell culture media.

The strategic partnership with Amino GmbH and the launch of BioXPro™ represent a significant step in Croda's strategy to expand its bioprocessing capabilities and deliver high-quality solutions for the pharmaceutical and biomanufacturing sector.

More information